Antihypertensive medication nonadherence is highly prevalent, leading to uncontrolled blood pressure. Methods that facilitate the targeting and tailoring of adherence interventions in clinical settings are required. Group-Based Trajectory Modeling (GBTM) is a newer method to evaluate adherence using pharmacy dispensing (refill) data that has advantages over traditional refill adherence metrics (e.g. Proportion of Days Covered) by identifying groups of patients who may benefit from adherence interventions, and identifying patterns of adherence behavior over time that may facilitate tailoring of an adherence intervention. We evaluated adherence to antihypertensive medication in 905 patients over a 12-month period in a community pharmacy setti...
Background and Objective: Detection and treatment of hypertension continues to be a major public hea...
Background: Non-adherence to treatment has been identified as the main cause of uncontrolled blood p...
What is known and objectives: About half of all patients taking antihypertensives discontinue treatm...
This thesis aimed to identify the evidence base regarding determinants, outcomes, and measures of an...
Poor adherence with antihypertensive therapies is a major factor in the low rates of blood pressure ...
Nonadherence to antihypertensive medicines limits their effectiveness, increases the risk of adverse...
The use of group-based trajectory modelling (GBTM) within the medication adherence literature is rap...
The use of group-based trajectory modelling (GBTM) within the medication adherence literature is rap...
The use of group-based trajectory modelling (GBTM) within the medication adherence literature is rap...
Nonadherence is a common reason for treatment failure and treatment resistance. No matter how it is ...
Hypertension (HTN) is a major risk factor for cardiovascular diseases. Suboptimal medication adheren...
The use of group-based trajectory modelling (GBTM) within the medication adherence literature is rap...
Antihypertensive pharmacotherapy is associated with poor adherence. No validated method exists to es...
Background: Medication adherence is essential to optimizing blood pressure (BP) control. Prior resea...
Introduction: Non-adherence to medication is a complex health care problem. In spite of substantial ...
Background and Objective: Detection and treatment of hypertension continues to be a major public hea...
Background: Non-adherence to treatment has been identified as the main cause of uncontrolled blood p...
What is known and objectives: About half of all patients taking antihypertensives discontinue treatm...
This thesis aimed to identify the evidence base regarding determinants, outcomes, and measures of an...
Poor adherence with antihypertensive therapies is a major factor in the low rates of blood pressure ...
Nonadherence to antihypertensive medicines limits their effectiveness, increases the risk of adverse...
The use of group-based trajectory modelling (GBTM) within the medication adherence literature is rap...
The use of group-based trajectory modelling (GBTM) within the medication adherence literature is rap...
The use of group-based trajectory modelling (GBTM) within the medication adherence literature is rap...
Nonadherence is a common reason for treatment failure and treatment resistance. No matter how it is ...
Hypertension (HTN) is a major risk factor for cardiovascular diseases. Suboptimal medication adheren...
The use of group-based trajectory modelling (GBTM) within the medication adherence literature is rap...
Antihypertensive pharmacotherapy is associated with poor adherence. No validated method exists to es...
Background: Medication adherence is essential to optimizing blood pressure (BP) control. Prior resea...
Introduction: Non-adherence to medication is a complex health care problem. In spite of substantial ...
Background and Objective: Detection and treatment of hypertension continues to be a major public hea...
Background: Non-adherence to treatment has been identified as the main cause of uncontrolled blood p...
What is known and objectives: About half of all patients taking antihypertensives discontinue treatm...